GlassScriptPhysician profile
Howard B Chrisman
NPI 1053373720
$53,364.40
in general payments reported to CMS, 2019-2025
9 companies · $668 in 2025
The $668 reported for 2025 was more than what 82% of Diagnostic Radiology providers received nationally (typical 2025 total: $112).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $19K · 2020: $24.50 · 2022: $8,202 · 2023: $25K · 2024: $568 · 2025: $668.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $25K · Food and Beverage: $1,136.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $25,092.99 |
| Food and Beverage | $1,135.63 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Siemens Medical Solutions USA, INC. | $47,343.99 | 2019-2025 | Magnetom Free.Max, Multitom Rax, Biograph Vision 600 (8 Ring/64 Ct) |
| Philips North America LLC | $5,820.75 | 2023 | |
| Terumo Medical Corporation | $44.55 | 2019-2020 | |
| W. L. Gore & Associates, INC. | $38.39 | 2024 | Gore Viabil Biliary Endoprosthesis, Viatorr Tips Endoprosthesis W/ Controlled Expansion |
| Bard Peripheral Vascular, INC. | $36.02 | 2019 | |
| Canon Medical Systems USA, INC. | $32.57 | 2019 | |
| Penumbra, INC. | $18.66 | 2024 | Penumbra System |
| Boston Scientific Corporation | $18.00 | 2022 | |
| C. R. Bard, INC. & Subsidiaries | $11.47 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Howard Chrisman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.